Efficient electroporation of liposomes doped with pore stabilizing nisin

Journal of Liposome Research

Volumn 23, Issue 3, 2013, Pages 197-202

  Yi, Jiang ^a,b   Barrow, Andrew J ^a,c   Yu, Nam ^a   O'Neill, Brian E ^a  

^a HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^b XINJIANG MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

Active release; Amphiphilic peptide; Electroporation; Lantibiotic; Lipid bilayer

Indexed keywords

6 CARBOXYFLUORESCEIN; AMPHOPHILE; DETERGENT; DRUG CARRIER; LIPOSOME; NISIN;

ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG RELEASE; ELECTRIC FIELD; ELECTRIC POTENTIAL; ELECTROPORATION; IN VIVO STUDY; LIPID BILAYER; PRIORITY JOURNAL; TUMOR ABLATION;

ELECTROPORATION; FLUORESCEINS; FLUORESCENT DYES; LIPOSOMES; NISIN;

EID: 84880458936     PISSN: 08982104     EISSN: 15322394     Source Type: Journal    
DOI: 10.3109/08982104.2013.788024     Document Type: Article

References (54)

1. Ahmed M, Moussa M, Goldberg SN. (2012). Synergy in cancer treatment between liposomal chemotherapeutics and thermal ablation. Chem Phys Lipids 165:424-37.
2. Al-Sakere B, André F, Bernat C, et al. (2007). Tumor ablation with irreversible electroporation. PLoS One 11:e1135. doi:10.1371/journal.pone. 0001135.
3. Anderson LJE, Hansen E, Lukianova-Hleb EY, et al. (2010). Optically guided controlled release from liposomes with tunable plasmonic nanobubbles. J Control Rel 144:151-8.
4. Ayuni EL, Gazdhar A, Giraud MN, et al. (2010). In vivo electroporation mediated gene delivery to the beating heart. PLoS One 5:e14467. doi:10.1371/journal.pone.0014467.
5. Bagla S, Papadouris D. (2012). Percutaneous irreversible electroporation of surgically unresectable pancreatic cancer: a case report. J Vasc Interv Radiol 23:142-5.
6. Bierbaum G, Sahl H-G. (2009). Lantibiotics: mode of action, biosynthesis and bioengineering. Curr Pharm Biotechnol 10:2-18.
7. Bodles-Brakhop AM, Heller R, Draghia-Akli R. (2009). Electroporation for the delivery of DNA-based vaccines and immunotherapeutics: current clinical developments. Mol Ther 17:585-92.
8. Breukink E, de Kruijff B. (2006). Lipid II as a target for antibiotics. Nat Rev Drug Discov 5:321-32.
9. Brötz H, Sahl HG. (2000). New insights into the mechanism of action of lantibiotics-diverse biological effects by binding to the same molecular target. J Antimicrob Chemother 46:1-6.
10. Cemazar M, Sersa G, Wilson J, et al. (2002). Effective gene transfer to solid tumors using different nonviral gene delivery techniques: electroporation, liposomes, and integrin-targeted vector. Cancer Gene Ther 9:399-406.
11. Charoo NA, Rahman Z, Repka MA, Murthy SN. (2010). Electroporation: an avenue for transdermal drug delivery. Curr Drug Deliv 7:125-36.
12. Chen C, Smye SW, Robinson MP, Evans JA. (2006). Membrane electroporation theories: a review. Med Biol Eng Comput 44:5-14.
13. Chu CJ, Dijkstra J, Lai MZ, et al. (1990). Efficiency of cytoplasmic delivery by pH-sensitive liposomes to cells in culture. Pharm Res 7: 824-34.
14. Correa NM, Schelly ZA. (1998). Dynamics of electroporation of synthetic liposomes studied using a pore-mediated reaction, Ag\+\+Br-!AgBr. J Phys Chem B 102:9319-22.
15. Davalos RV, Mir ILM, Rubinsky B. (2005). Tissue ablation with irreversible electroporation. Ann Biomed Eng 33:223-31.
16. Delemotte L, Tarek M. (2012). Molecular dynamics simulations of lipid membrane electroporation. J Membr Biol 245:531-43.
17. Driessen AJ, van den Hooven HW, Kuiper W, et al. (1995). Mechanistic studies of lantibiotic-induced permeabilization of phospholipid vesicles. Biochemistry 34:1606-14.
18. de Smet M, Langereis S, van den Bosch S, Grüll H. (2010). Temperature-sensitive liposomes for doxorubicin delivery under MRI guidance. J Control Rel 143:120-7.
19. Fosnaric M, Kralj-Iglic V, Bohinc K, et al. (2003). Stabilization of pores in lipid bilayers by anisotropic inclusions. J Phys Chem B 107: 12519-26.
20. Geers B, Lentacker I, Sanders NN, et al. (2011). Self-assembled liposome-loaded microbubbles: the missing link for safe and efficient ultrasound triggered drug-delivery. J Control Rel 152:249-56.
21. Hanke W, Methfessel C, Wilmsen HU, et al. (1983). Melittin and a chemically modified trichotoxin form alamethicin-type multi-state pores. Biochim Biophys Acta 727:108-14.
22. Hasper HE, de Kruijff B, Breukink E. (2004). Assembly and stability of nisin-lipid II pores. Biochemistry 43:11567-75.
23. Hasper HE, Kramer NE, Smith JL, et al. (2006). An alternative bactericidal mechanism of action for lantibiotic peptides that target lipid II. Science 313:1636-7.
24. Hauck ML, LaRue SM, Petros WP, et al. (2006). Phase I trial of doxorubicin-containing low temperature sensitive liposomes in spontaneous canine tumors. Clin Cancer Res 12:4004-10.
25. Heller LC, Jaroszeski MJ, Coppola D, Heller R. (2008). Comparison of electrically mediated and liposome-complexed plasmid DNA delivery to the skin. Gen Vac Ther 6:16.doi:10.1186/1479-0556-6-16.
26. Huang S, Hamilton AJ, Tiukinhoy SD, et al. (2002). Liposomes as ultrasound imaging contrast agents and as ultrasound-sensitive drug delivery agents. Cell Mol Biol Lett 7:233-5.
27. Kanduser M, Fosnaric M, Sentjurc M, et al. (2003). Effect of surfactant polyoxyethylene glycol (C12E8) on electroporation of cell line DC3F. Coll Surf A: Physicochem Eng Aspects, 214, 205-17.
28. Karatekin E, Sandre O, Guitouni H, et al. (2003). Cascades of transient pores in giant vesicles: line tension and transport. Biophys J 84: 1734-49.
29. Khoobehi B, Char CA, Peyman GA. (1990). Assessment of laserinduced release of drugs from liposomes: an in vitro study. Lasers Surg Med 10:60-5.
30. Kramar P, Delemotte L, Mac?ek-Lebar A, et al. (2012). Molecular-level characterization of lipid membrane electroporation using linearly rising current. J Membr Biol 245:651-9.
31. Lee EW, Thai S, Kee ST. (2010). Irreversible electroporation: a novel image-guided cancer therapy. Gut Liver 4:S99-S104.
32. Liu X, Zheng Y, Samoshina NM, et al. (2012). Fliposomes: pH-triggered conformational flip of new trans-2-aminocyclohexanol-based amphiphiles causes instant cargo release in liposomes. J Liposome Res 22: 319-28.
33. Mignet N, Vandermeulen G, Pembouong G, et al. (2010). Cationic and anionic lipoplexes inhibit gene transfection by electroporation in vivo. J Gene Med 12:491-500.
34. Momekova D, Rangelov S, Lambov N. (2010). Long-circulating, pH-sensitive liposomes. Meth Mol Biol 605:527-44.
35. Neal RE, Rossmeisl Jr JH, Garcia PA, et al. (2011). Successful treatment of a large soft tissue sarcoma with irreversible electroporation. J Clin Oncol 29:e372-7.
36. Northfelt DW, Dezube BJ, Thommes JA, et al. (1997). Efficacy of pegylated-liposomal doxorubicin in the treatment of AIDS-related Kaposi's sarcoma after failure of standard chemotherapy. J Clin Oncol 15:653-9.
37. Paartanen A, Yarmolenko PS, Viitala A, et al. (2012). Mild hyperthermia with magnetic resonance-guided high-intensity focused ultrasound for applications in drug delivery. Int J Hyperther 28:320-36.
38. Pavlin M, Kotnik T, Miklavc?ic? D, et al. (2008). Electroporation of planar lipid bilayers and membranes. In: Liu AL, ed. Advances in planar lipid bilayers and liposomes. Vol. 6. London, UK: Academic Press, 165-226.
39. Qin G, Li Z, Xia R, et al. (2011). Partially polymerized liposomes: stable against leakage yet capable of instantaneous release for remote controlled drug delivery. Nanotechnology 22:155605.doi:10.1088/0957-4484/22/15/ 155605.
40. Rodriguez N, Cribier S, Pincet F. (2006). Transition from long-to shortlived transient pores in giant vesicles in an aqueous medium. Phys Rev E: Stat Nonlin Soft Matter Phys 74:061902.doi:10.1103/PhysRevE.74.061902.
41. Sablon E, Contreras B, Vandamme E. (2000). Antimicrobial peptides of lactic acid bacteria: mode of action, genetics and biosynthesis. Adv Biochem Eng Biotechnol 68:21-60.
42. Schroeder A, Kost J, Barenholz Y. (2009). Ultrasound, liposomes, and drug delivery: principles for using ultrasound to control the release of drugs from liposomes. Chem Phys Lipids 162:1-16.
43. Simões S, Moreira JN, Fonseca C, et al. (2004). On the formulation of pH-sensitive liposomes with long circulation times. Adv Drug Deliv Rev 56:947-65.
44. Tagami T, Ernsting MJ, Li S-D. (2011). Efficient tumor regression by a single and low dose treatment with a novel and enhanced formulation of thermosensitive liposomal doxorubicin. J Control Rel 152:303-9.
45. Tarek M. (2005). Membrane electroporation: a molecular dynamics simulation. Biophys J. 88:4045-53.
46. Tieleman DP. (2004). The molecular basis of electroporation. BMC Biochem 5:10.doi:10.1186/1471-2091-5-10.
47. Tung L, Troiano GC, Sharma V, et al. (1999). Changes in electroporation thresholds of lipid membranes by surfactants and peptides. Ann N Y Acad Sci 888:249-65.
48. Volodkin DV, Skirtach AG, Möhwald H. (2009). Near-IR remote release from assemblies of liposomes and nanoparticles. Angew Chem Int Ed Engl 48:1807-9.
49. Weinstein JN, Magin RL, Yatvin MB, Zaharko DS. (1979). Liposomes and local hyperthermia: selective delivery of methotrexate to heated tumors. Science 204:188-91.
50. Wells JM, Li LH, Sen A, et al. (2000). Electroporation-enhanced gene delivery in mammary tumors. Gene Ther 7:541-7.
51. Wiedemann I, Benz R, Sahl H-G. (2004). Lipid II-mediated pore formation by the peptide antibiotic nisin: a black lipid membrane study. J Bacteriol 186:3259-61.
52. Yatvin MB, Kreutz W, Horwitz BA, Shinitzky M. (1980). pH-sensitive liposomes: possible clinical implications. Science 210: 1253-5.
53. Zeng H, Vanga RR, Marynick DS, Schelly ZA. (2008). Cluster precursors of uncapped CdS quantum dots via electroporation of synthetic liposomes. Experiments and theory. J Phys Chem B 112: 14422-6.
54. Zhou R, Norton JE, Zhang N, Dean DA. (2007). Electroporation-mediated transfer of plasmids to the lung results in reduced TLR9 signaling and inflammation. Gene Ther 14: 775-80.